C-terminal amidation of neuropeptides Gly-Lys-Arg extension an efficient precursor of C-terminal amide by Gomez, Sophie et al.
Volume 167, number 1 FEBS 1231 February 1984 
C-terminal amidation of neuropeptides 
Gly-Lys-Arg extension an efficient precursor of C-terminal amide 
Sophie Gomez, Carlo di Belle+, Lam Than Hung*, Roger Genet*, Jean-Louis Morgat*, 
Pierre Fromageot* and Paul Cohen 
Groupe de Neurobiochimie Cellulaire et MolPculaire, Universitd Pierre et Marie Curie, 96 boulevard Raspail, 75006 
Paris, France, +Istituto di Chimica BioIogica, Universitci di Padova, 35100 Padova, Italy and *Service de 
Biochimie, Departement de Biologie, CEN Saclay, 91191 Gif-sur- Yvette, France 
Received 5 December 1983 
Biosynthesis of the C-terminal carboxamide group of peptide hormones was studied using comparatively 
pGlu-His-Pro-Gly and Glu-His-Pro-Gly-Lys-Arg as putative precursors of the tripeptide, thyroliberin 
(TRH). Rat hypothalamus granules were found to contain an amide group forming activity which converts 
both peptide substrates into TRH. Comparison of the rate of conversion of the two substrates indicated 
that the C-terminal dibasic extension favored a IO-fold increase in the production of amidated peptide. 
It is suggested that this type of structure may be present in the putative biosynthetic precursor of TRH 
and that it may provide a better substrate for the enzyme(s) involved in C-terminal amidation. 
Thyroliberin Hypothalamic granule 
1. INTRODUCTION 
Several biologically active peptides with a C- 
terminal carboxamide group usually appear to be 
followed by the sequence Gly-X-X (where X is 
either Lys or Arg) when still included in their 
precursor [l-4]. This observation suggested that 
the biosynthesis of the C-terminal amide might in- 
volve specific enzyme(s) processing a vicinal C- 
terminal glycine. Recent in vitro studies, using syn- 
thetic substrates derived from D-Tyr-Val-Gly, 
demonstrated that the mechanism of amidation in- 
volves dehydrogenation and hydrolysis of the 
glycine extended peptide by pituitary granule en- 
zyme(s) [5-71. In addition, these studies suggested 
that the carboxyl group of Gly must be free in 
Abbreviations: TRH, pGlu-His-Pro(NH2) (thyrolibe- 
rin); TRH-Gly, pGlu-His-Pro-Gly; TLC, thin-layer 
chromatography; HPLC, high-performance liquid chro- 
matography; CMC, carboxymethylcellulose; CRF, cor- 
ticotropin releasing factor 
TRH-Gly TRH-G/y-Lys-Arg 
order to be recognized by the amide group forming 
enzyme [5,6]. It was thus proposed that a similar 
mechanism could be involved in the C-terminal 
carboxamidation of hormones and neuropeptides 
in various tissues [B]. 
To assess the validity of the above proposed 
hypothesis, these studies have however to be ex- 
tended to other substrates, particularly those con- 
taining either a C-terminal Gly extension or a Gly- 
X-X extension of a naturally occurring sequence. 
The possibility that a dibasic extension could serve 
as an additional recognition signal for the en- 
zyme(s) into the sequence of the biosynthetic 
precursor has to be tested. Studies of the enzymatic 
amidation processes of TRH were initiated by us- 
ing both TRH-Gly and Glu-His-Pro-Gly-Lys-Arg 
as substrates and purified rat hypothalamus 
granules as a source for amidation activity. This 
choice reflects: 
(i) the fact that TRH is a natural, C-terlninal car- 
boxamidated, hormone which is synthesized at 
its highest level by the hypothalamus, and 
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(ii) the proposal that TRH may derive from the 
processing of a larger peptide precursor [9]. 
We report here an analysis of the ability of 
hypothalamic granule extracts to convert TRH-Gly 
and Glu-His-Pro-Gly-Lys-Arg into TRH. The data 
give support to the hypothesis that both amidation 
and processing of active peptides might be con- 
certed mechanisms. 
2. MATERIALS AND METHODS 
TRH was provided by CRB, Cambridge. 
Depyrolyzed TRH was obtained from Penninsula 
Lab., San Carlos, CA. TRH-Giy and Glu-His-Pro- 
Gly-Lys-Arg were synthesized by an improved pro- 
cedure of the solid phase method. Crude peptides 
were cleaved from the resin by liquid HF at 0°C 
and passed through Sephadex G-10 in 0.5 N acetic 
acid. Final purification was effected by 
chromatography on CMC followed by HPLC on a 
C-18 Bondapack column (250 x 4.6 mm) eluted by 
5% acetonitrile, hexanesulfonate (1 g/l) in 20 mM 
acetic acid. The purity of the peptides was assessed 
by amino acid analysis on a Carlo Erba 3A28 
automatic analyzer, TLC on cellulose plate run in 
two different solvent systems and HPLC as 
described above. Preparation and purification of 
highly labelled [3H]TRH-Gly (25 Ci/mmol) and 
[3H]Glu-His-Pro-Gly-Lys-Arg (22 Ci/mmol) was 
achieved by the same methodology as previously 
used for tritiation of TRH [IO]. 
A purified fraction of hypothalamus granule 
was prepared involving both differential and Per- 
co11 gradient centrifugations. H~othalami from 
adult male rats (Wistar, 100 g) were homogenized 
with a Potter Elvejhem in 20 mM Tris-HCl buffer 
(pH 7.4) containing 0.25 M sucrose. All the ex- 
periments were run at 4°C. The homogenate was 
centrifuged at 10000 x g for 10 min, then at 25000 
x g for 20 min. The pellet was resuspended in buf- 
fered isotonic sucrose and centrifuged at 25000 x 
g for 20 min. The final sediment was considered as 
a crude granular fraction [ 1 l] and was resuspended 
in 1 ml of isotonic buffered sucrose. This prepara- 
tion was further purified by s~imentation at 
60000 x g for 30 min on a continuous 33% Percoll 
gradient made in 0.25 M sucrose as in [12]. Two 
major bands appeared under these conditions, the 
lower (e = 1.08) mainly consisting of secretory 
granules free from lysosomal or mitochondrial 
contaminants [12]. Fractions (0.6 ml) were col- 
lected from the Percoll gradient (16 ml) and then 
diluted to 6 ml by 5 mM Tes buffer (pH 7) and 
gently stirred for 30 min at 4°C. The membrane- 
bound components were removed by centrifuga- 
tion at 30000 x g for 30 min and the supernatants 
were tested for their amidating activity. 
The assay system for detecting and estimating 
amidating activity was based on the ability of en- 
zyme preparations to convert the synthetic 
substrates TRH-Gly or Glu-His-Pro-Gly-Lys-Arg 
to TRH or Glu-His-Pro(NHz), respectively. Assays 
were carried out at 37’C [in 0.1 M Tes buffer (pH 
7) in a total volume of 220 ~11 and with 200 ~1 of 
each lysed gradient fraction containing 10~1 
(0.3 ,Ki) of either tritiated TRH-Gly or Glu-His- 
Pro-Gly-Lys-Arg and 10 $1 of 0.2 mM bacitracin. 
After 5 h, the reaction was terminated by the addi- 
tion of HCl to a final concentration of 1 N. 
Acidified incubation solutions were centrifuged at 
15000 x g for 10 min and the resulting super- 
natants were evaporated to dryness and resuspend- 
ed in the appropriate buffer for TLC or HPLC 
analysis. 
TLC was carried out on cellulose plates (10 x 
10 cm) developed in chlorofo~-methanol-am- 
monia (5 : 3 : I, by vol.) for 30 min at 20°C. The 
peptides were detected by spraying with Pauli 
reagent. Areas corresponding to the position of 
TRH were eluted from the support by pure water 
and eluates were submitted to HPLC on an ap- 
paratus from Beckman Instruments equipped with 
All0 pumps directed by a 421 controller. A re- 
verse-phase C-18 column (250 x 4.6 mm, Bonda- 
pack, Merck) eluted at a flow rate of 1 ml - min-’ 
was used. Elution was performed isocratically by a 
mixture of 5% acetonitrile, hexanesulfonate 
(1 g/l) in 20 mM acetic acid. Counting of the 
radioactivity was done on aliquots of each fraction 
by means of a liquid scintillation spectrometer (In- 
tertechnique SL 30) using toluene-based medium. 
Products formed from each substrate were iden- 
tified by their retention time as compared to syn- 
thetic reference peptides. 
Under these conditions, a yield of approx. 2% 
was obtained for the amidation reaction. 
Control assays, carried out with omission of the 
extract, showed that the substrates were stable 
under the conditions described. 
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3. RESULTS AND DISCUSSION 
Detectable amounts either of labelled TRH or 
depyrolyzed TRH were formed upon incubation 
for 5 h at 37°C of pGlu-His-Pro-Gly or Glu-His- 
Pro-Gly-Lys-Arg with aliquots of hypothalamus 
granule extracts (fig.l,2). The identity of the 
tritiated amide peptides generated by the extract 
was established by comparing their behavior with 
those of synthetic TRH or depyrolyzed TRH on 
TLC and/or reverse-phase HPLC (fig. 1,2). Fig.2B 
shows that a small amount of radioactive Glu-His- 
Pro-Gly was additionally found aside Glu-His- 
Pro(NHz) when the hexapeptide was used as 
primary substrate. Analysis of the Percoll gradient 
indicated that the amide group forming activity 
was concentrated into the granule fractions (Q = 
1.08) where it attained its highest specific activity 
(not shown). Activity could be readily solubilized 
by osmotic shock of the granules. Further 
characterization of the enzyme activity was 
achieved through filtration on Sephadex G-100 of 
the granule lysate. The amidating activity emerged 
in a single peak (fig.1) indicating an apparent 
molecular mass of approx. 60 kDa. The amounts 
of amidated peptides generated respectively from 
TRH-Gly and Glu-His-Pro-Gly-Lys-Arg, under 
similar experimental conditions, are shown in table 
1. The hexapeptide is a IO-times better substrate 
than TRH-Gly. Cyclisation of the N-terminal Glu 
took place, to a limited extent, as shown by the 
formation of TRH from Glu-His-Pro-Gly-Lys- 
Arg. 
The finding that Gly-Lys-Arg C-terminal exten- 
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Fig.1. Identification of TRH produced by incubation of TRH-Gly with extract from rat hypothalamus granules. 
Tritiated TRH-Gly (0.3 ,&i) was incubated at 37”C, pH 7, with 200 ~1 of granule lysate obtained from a Percoll gradient 
(fractions 7 and 8, d = 1.08). Incubation and analysis of the products were performed as described in section 2. Arrow 
indicates the retention time of synthetic TRH run under identical conditions. (Inset) Partial purification of the 
amidating activity from rat hypothalamus granules. An extract prepared from the secretory granule fraction of 
hypothalamus was filtered on a precalibrated Sephadex G-100 column (1.2 x 100 cm), equilibrated and eluted with 
0.1 M ammonium acetate buffer (pH 7) at a flow rate of 4 ml/h. Each fraction (1 ml) was assayed for amidating activity 
as described above. Amide forming activity elutes like a 60-kDa molecular form. 
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sion acts as a better substrate for the carboxamide 
activity than glycine alone suggests that the latter 
[5,6] is a minimal requirement. Indeed, if the result 
we observed could partly be explained by a step- 
wise action of trypsin-like and carboxypeptidase- 
like enzymes [ 131 on Glu-His-Pro-Gly-Lys-Arg 
followed by dehydrogenation and hydrolysis of the 
remaining tetrapeptide, we should have observed a 
higher,. or at least the same, amount of amide pro- 
duct by using TRH-Gly as substrate. We thus have 
to assume that basic residue(s) can be involved in 
the recognition by specific amidating enzyme(s) 
and/or participate in the mechanism of amidation 
in a still unknown manner. 
Fig.%. Identification of Glu-His-Pro-NH2 and TRH 
produced by incubation of Glu-His-Pro-Gly-Lys-Arg 
with extract from rat hypothalamus granules. The assay 
system for detecting and estimating amidating activity 
using tritiated Glu-His-Pro-Gly-Lys-Arg. as primary 
substrate was conducted as described infig. 1 except that 
TLC analysis was replaced at first by an HPLC, 
preparative, run. (A) The fractions corresponding to 
retention times of 13-15 min. from the first HPLC, 
were pooled, concentrated, and rerun on HPLC under 
the same experimental conditions as in fig.1. (B) The 
fractions corresponding to retention times of 17-19 min 
and 26-28 min, from the first HPLC, were pooled, 
concentrated, and rerun under similar conditions as in 
fig.1. Arrows indicate the respective retention times of 
synthetic TRH, Glu-His-Pro(NH2) and Glu-His-Pro- 
Gly. 
A recent report [14] indicated that the precursor 
for another C-terminal amide peptide, CRF, 
presents a Gly-Lys extension at its C-terminus. The 
differential rates of amidation we observed strong- 
ly suggest thus that C-terminal basic residue(s), 
which potentiate(s) amidation, are involved in a 
concerted mechanism with Gly, even though these 
basic amino acids have first to be sequentially 
removed. In line with this, the finding [6] that no 
amidation occurred using D-Tyr-Val-Gly-Lys as 
substrate is perplexing although it might be due to 
differences between experimental conditions used 
in that study (nature of substrates and source of 
enzyme activities), and the present one. In any 
case, the present data and [ 141 raise the hypothesis 
that the presence of a C-terminal basic amino acid 
residue(s) is required to confer on a substrate the 
ability to be recognized by amidating enzyme(s) 
that act on the hormonal sequence ither included 
in its biosynthetic precursor form or after its 
cleavage. 
Table 1 
Amounts of amidated products obtained by incubation of either TRH-Gly or Glu-His-Pro-Gly-Lys- 
Arg 3H-labelled peptides with granule extracts from rat hypothalami 
Primary substrate used Amount of generated Amount of amidated 
products products 
[‘H]TRH [3H]Glu-His-Pro-NHz 
2.7 pg - 2.7 pg 
4.8 pg 21.2 pg 26 pg 
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